INCEPT : The Intensive Care Platform Trial—Design and protocol
Acta Anaesthesiologica Scandinavica · 2025
DOI: 10.1111/aas.70023 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2025. Verfasst von Anders Granholm und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Critical Care, Intensive Care Units, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dagmar Marshalls Fond, Grosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs Fond, Sygeforsikringen 'danmark'.
Themen: Intensivpflege
Abstract (Originalsprache)
Background
Adult intensive care unit (ICU) patients receive many interventions, but few are supported by high‐certainty evidence. Randomised clinical trials (RCTs) are essential for trustworthy comparisons of intervention effects, but conventional RCTs are costly, cumbersome, inflexible, and often turn out inconclusive. Adaptive platform trials may mitigate these issues and have higher probabilities of obtaining conclusive results faster and at lower costs per participant.
Methods
The Intensive Care Platform Trial ( INCEPT ) is an investigator‐initiated, pragmatic, randomised, embedded, multifactorial, international, adaptive platform trial including adults acutely admitted to ICUs. INCEPT will assess comparable groups of interventions (primarily commonly used interventions with clinical uncertainty and practice variation) nested in domains. Interventions may be either open‐label or masked. New domains will continuously be added to the platform. INCEPT assesses multiple core outcomes selected following substantial stakeholder involvement: mortality, days alive without life support/out of hospital/free of delirium, health‐related quality of life, cognitive function, and safety outcomes. Each domain will use one of these core outcomes as the primary outcome. INCEPT primarily uses Bayesian statistical methods with neutral, minimally informative or sceptical priors, adjustment for important prognostic baseline variables, and calculation of absolute and relative differences in the intention‐to‐treat populations. Domains and intervention arms may be stopped for superiority/inferiority, practical equivalence, or futility according to pre‐specified adaptation rules evaluated using statistical simulation or at pre‐specified maximum sample sizes. Domains may use response‐adaptive randomisation, meaning that more participants will be allocated to interventions with higher probabilities of being superior.
Conclusions
INCEPT provides an efficient, pragmatic, and flexible platform for comparing the effects of many interventions used in adult ICU patients. The adaptive design enables the trial to use accumulating data to improve the treatment of future participants. INCEPT will provide high‐certainty, conclusive evidence for many interventions, directly inform clinical practice, and thus improve patient‐important outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Intensive Care, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
- Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
- Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.
ORCID-Profile: Anders Granholm, Benjamin Skov Kaas-Hansen, Marie Warrer Munch, Maj-Brit Nørregaard Kjær, Lars Wiuff Andersen, Olav Lilleholt Schjørring, Bodil Steen Rasmussen, Tine Sylvest Meyhoff, Marie Oxenbøll Collet, Nick Frørup Meier, Ole Mathiesen, Mathias Maagaard, Anne Craveiro Brøchner, Martin Siegemund, Theis Lange
Förderung
- Dagmar Marshalls Fond
- Grosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs Fond
- Sygeforsikringen 'danmark'
- Novo Nordisk Fonden
- Danmarks Frie Forskningsfond
- Savværksejer Jeppe Juhl og hustru Ovita Juhls Mindelegat
Zitieren
APA
Granholm, A., Møller, M. H., Kaas-Hansen, B. S., Jensen, A. K. G., Munch, M. W., Kjær, M. N., Andersen, L. W., Schjørring, O. L., Rasmussen, B. S., Meyhoff, T. S., Larsen, R. F., Thorsen-Meyer, H. C., Collet, M. O., Meier, N. F., Estrup, S., Mathiesen, O., Maagaard, M., Poulsen, L. M., Strøm, T., …, & Perner, A. (2025). INCEPT : The Intensive Care Platform Trial—Design and protocol. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.70023
Vancouver
Granholm A, Møller MH, Kaas-Hansen BS, Jensen AKG, Munch MW, Kjær MN, et al. INCEPT : The Intensive Care Platform Trial—Design and protocol. Acta Anaesthesiologica Scandinavica. 2025. doi:10.1111/aas.70023
BibTeX
@article{Granholm2025,
author = {Granholm, Anders and Møller, Morten Hylander and Kaas-Hansen, Benjamin Skov and Jensen, Aksel Karl Georg and Munch, Marie Warrer and Kjær, Maj-Brit Nørregaard and Andersen, Lars Wiuff and Schjørring, Olav Lilleholt and Rasmussen, Bodil Steen and Meyhoff, Tine Sylvest and Larsen, Rikke Faebo and Thorsen-Meyer, Hans-Christian and Collet, Marie Oxenbøll and Meier, Nick Frørup and Estrup, Stine and Mathiesen, Ole and Maagaard, Mathias and Poulsen, Lone Musaeus and Strøm, Thomas and Christensen, Steffen and Bruun, Camilla Rahbek Lysholm and Keus, Frederik and Rossing, Peter and Granfeldt, Asger and Brøchner, Anne Craveiro and Itenov, Theis Skovsgaard and Cronhjort, Maria and Laake, Jon Henrik and Hästbacka, Johanna and Pfortmueller, Carmen Andrea and Siegemund, Martin and Sigurdsson, Martin Ingi and Andersen, Lars Peter Kloster and Placido, Davide and Lange, Theis and Perner, Anders},
title = {INCEPT : The Intensive Care Platform Trial—Design and protocol},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2025},
doi = {10.1111/aas.70023}
}
EUVIMED